Project Grant ORIIR240081

Award Date 9/30/24
Completion Date 9/29/25
Dollars Obligated $47K
Funding Federal Agency
Office of Research Integrity
Awarding Federal Agency
Office of Grants Management
Federal Grant Program
93.085
Assistance Type
Project Grant
Place of Performance
Pennsylvania, USA
Similar Awards
This Project Grant award from the National Science Foundation (NSF) Office of Integrative Activities (CFDA 47.083) will provide $100,000 to Nova Southeastern University in Florida to host a series of conferences focused on supporting early-career faculty and enhancing research infrastructure at emerging research institutions and minority-serving institutions. The conferences will bring together research development professionals, university administrators, and early-career faculty to capture...
The National Science Foundation (NSF) Office of Integrative Activities awarded a $100,000 Project Grant to the University of California, Santa Barbara (UCSB) to host a conference on "Inclusive Collaboration Resources: Enhancing Research Support Infrastructure at Minority Serving Institutions." The goal is to develop best practices and resources to improve equitable research collaboration and retention of diverse STEM researchers. The conference will convene research enterprise...
This Project Grant award from the National Institute of General Medical Sciences (NIGMS) under the Biomedical Research and Research Training program (CFDA 93.859) provides $4,344,407 to the University of Pittsburgh to test an intervention using structured cognitive behavioral training (SCBT) to address systemic inequities and promote inclusive excellence in the biomedical research workforce. The project will conduct a cluster randomized trial across 26 institutions, following participants for...
The Fogarty International Center (FIC) of the National Institutes of Health (NIH) awarded a $100,987 Project Grant under the International Research and Research Training program (CFDA 93.989) to Mu-Jhu Care LTD, a non-profit organization in Uganda. The three-year grant, awarded on May 19, 2025 and concluding on Feb 29, 2028, aims to strengthen the research compliance and integrity (RCI) capacity of the Makerere University-Johns Hopkins University (MU-JHU) Research Collaboration and other...
This Project Grant award, funded by the Agency for Healthcare Research and Quality (AHRQ) under the Research on Healthcare Costs, Quality and Outcomes (CFDA 93.226) program, supports a comprehensive $398,972 study on improving healthcare quality and equity for newborns with prenatal substance exposure. The study, conducted by the University of California, Davis in collaboration with the Better Outcomes through Research for Newborns (BORN) network and the EMPOWER stakeholder group, aims to:...
This Project Grant awarded by the National Science Foundation's Integrative Activities program (CFDA 47.083) provides $555,545 to Salve Regina University to enhance research administration capacity across five emerging research institutions (ERI) in Rhode Island. The collaboration, titled "Revisioning Research Administration in Rhode Island for Emerging Research Institutions (ERIS)," aims to: Develop shared resources and a research administration learning community; Build and diversify...
This Project Grant award, titled "ADDRESSING INSTITUTIONAL SEXUAL HARASSMENT TO IMPROVE PHYSICIAN WELL-BEING" (R01HS030246), was provided by the Center for Quality Improvement and Patient Safety, a division of the U.S. Department of Health and Human Services. The $1,000,000 award, effective from September 30, 2024 to July 31, 2028, supports research to understand and mitigate the impact of sexual harassment on physician well-being. The key activities under this grant include: 1)...
This federal Project Grant award for $399,999 from the Department of Health and Human Services' Agency for Healthcare Research and Quality (AHRQ) under the Research on Healthcare Costs, Quality and Outcomes (CFDA 93.226) program will support a multidisciplinary research project at Northeastern University focused on understanding and addressing community health center burden, resiliency, and burnout. The research aims to: 1) Understand the nature, extent, and issues with system resiliency,...
The National Science Foundation (NSF) awarded a $3,875,471 Project Grant under the Integrative Activities (CFDA 47.083) program to the University of Maryland Baltimore County (UMBC) to develop a sustainable model for building capacity at mid-sized and smaller research universities to implement new federal research security policies. The project aims to create, test, and implement a "Research Integrity, Security, and Compliance (RISC) Roadmap" - a publicly accessible information...
This Project Grant award from the Agency for Healthcare Research and Quality (AHRQ) under the Research on Healthcare Costs, Quality and Outcomes (CFDA 93.226) program will provide $275,000 in funding to the University of Texas Health Science Center at Houston from August 1, 2024 to July 31, 2026. The project aims to develop and test strategies to increase implementation of evidence-based interventions through collaboration with patient advocacy groups in the areas of juvenile idiopathic...

CULTIVATING RESEARCH INTEGRITY: ESSENTIAL FOR TRANSITIONING FROM A COMMUNITY HOSPITAL INTO AN ACADEMIC MEDICAL CENTER - A. PROJECT DESCRIPTION: READING HOSPITAL, THE FLAGSHIP HOSPITAL OF TOWER HEALTH, IS SUBMITTING THIS APPLICATION IN RESPONSE TO THE NOTICE OF FUNDING OPPORTUNITY (IR-OR-24-001): ENSURING RESEARCH INTEGRITY - CONFERENCES. OUR PROPOSED CONFERENCE AIMS TO PROVIDE A FORUM FOR EDUCATION ON RESEARCH INTEGRITY, EXCHANGE OF BEST PRACTICES, NETWORKING, AND PRODUCING TANGIBLE OUTCOMES PRIMARILY RELATED TO THE FIRST TWO THEMES LISTED IN THE NOFO - 1) FOSTERING AN ENVIRONMENT THAT PROMOTES RESEARCH INTEGRITY AND THE RESPONSIBLE CONDUCT OF RESEARCH, AND 2) PREVENTION OF RESEARCH MISCONDUCT. SPECIFICALLY, THIS CONFERENCE PROPOSES TO EMPHASIZE THE IMPORTANCE AND IMPACT OF CULTIVATING RESEARCH INTEGRITY CULTURE IN A COMMUNITY HOSPITAL AS IT IS TRANSITIONING INTO AN ACADEMIC MEDICAL CENTER, THEREFORE ADDRESSING AN UNMET NEED IN THE RESEARCH INTEGRITY SPACE. THIS CONFERENCE ALSO INTENDS TO SHARE THE INSTITUTION'S EXPERIENCES AND LESSONS LEARNED DURING THEIR OWN TRANSITIONS AND DISSEMINATE BEST PRACTICES IN RESEARCH INTEGRITY TO THE CONFERENCE PARTICIPANTS. OUR APPROACH IS CONSISTENT WITH THE RECOMMENDATION FROM NATIONAL ACADEMIES OF SCIENCES ENGINEERS MEDICINE (2017): "RESEARCHERS, RESEARCH SPONSORS, AND RESEARCH INSTITUTIONS SHOULD CONTINUE TO DEVELOP AND ASSESS MORE EFFECTIVE EDUCATION AND OTHER PROGRAMS THAT SUPPORT THE INTEGRITY OF RESEARCH. THESE IMPROVED PROGRAMS SHOULD BE WIDELY ADOPTED ACROSS DISCIPLINES AND ACROSS NATIONAL BORDERS". 1. RATIONALE AND BACKGROUND: INTEGRITY IN RESEARCH IS A FUNDAMENTAL PILLAR OF RESEARCH EXCELLENCE AND PUBLIC TRUST OF SCIENTIFIC ADVANCEMENT THROUGH RESEARCH. IT ENCOMPASSES OBJECTIVITY, HONESTY, OPENNESS, FAIRNESS, ACCOUNTABILITY, AND STEWARDSHIP (NATIONAL ACADEMIES OF SCIENCES ENGINEERING AND MEDICINE (U.S.). COMMITTEE ON RESPONSIBLE SCIENCE. & COMMITTEE ON SCIENCE ENGINEERING MEDICINE AND PUBLIC POLICY (U.S.), 2017). DESPITE SIGNIFICANT PROGRESS IN RESEARCH ON INTEGRITY RESEARCH AND ENHANCED OVERSIGHT AT FEDERAL, LOCAL, AND INSTITUTIONAL LEVELS, EROSIONS OF RESEARCH INTEGRITY AND MISCONDUCT CONTINUE TO RISE. IN 2022, OFFICE OF RESEARCH INTEGRITY (ORI) RECEIVED 269 ALLEGATIONS (THE U.S. DEPARTMENT OF HEALTH AND HUMAN SERVICES, 2022). RESEARCH MISCONDUCT IS DEFINED IN 42 CFR PART 93 AS FABRICATION, FALSIFICATION, OR PLAGIARISM IN PROPOSING, PERFORMING, OR REVIEWING RESEARCH, OR IN REPORTING RESEARCH RESULTS. EVEN THOUGH IT IS DIFFICULT TO ACCURATELY ASSESS THE "EPIDEMIOLOGY" OF RESEARCH MISCONDUCT, A RECENT META-ANALYSIS (PHOGAT ET AL., 2023) REPORTED THE PREVALENCE RATE (SELF-REPORT VS OBSERVED) OF 4.2% VS 27.9% FOR PLAGIARISM, 4.5% VS 21.7% FOR DATA FABRICATION, AND 9.7% VS 33.4% FOR DATA FALSIFICATION. IN CLINICAL RESEARCH INCLUDING CLINICAL TRIALS, RESEARCH MISCONDUCT MAY INVOLVE BROADER PRACTICES THAT CAN BE DEEMED QUESTIONABLE AND EVEN DETRIMENTAL TO THE WELLBEING OF STUDY SUBJECTS. EXAMPLES OF COMMON MISCONDUCT FINDINGS IN CLINICAL TRIALS INCLUDE FAILURE TO ADHERE TO RESEARCH PROTOCOLS; FAILURE TO REPORT SERIOUS ADVERSE EVENTS; REPEATED OR DELIBERATE FAILURE TO OBTAIN ADEQUATE INFORMED CONSENT; FAILURE TO OBTAIN INSTITUTIONAL REVIEW BOARD (IRB) REVIEW AND APPROVAL OF STUDY PROTOCOL OR CHANGES; FAILURE TO ADEQUATELY SUPERVISE THE CLINICAL TRIAL (GUPTA, 2013). THREE KEY CONTRIBUTING FACTORS TO RESEARCH MISCONDUCT INCLUDE INDIVIDUAL BEHAVIORS, INSTITUTIONAL ISSUES, AND STRUCTURAL ISSUES IN RESEARCH IN GENERAL (GUPTA, 2013). RESEARCH INTEGRITY RISK OR MISCONDUCT ESPECIALLY ASSOCIATED WITH INDIVIDUAL AND INSTITUTIONAL RISK FACTORS CAN BE FURTHER EXPOSED OR ELEVATED IN AN INSTITUTION THAT IS LESS EXPERIENCED IN CLINICAL RESEARCH AND LACK OF EFFECTIVE RESEARCH COMPLIANCE MECHANISMS, PROGRAMS, OR INFRASTRUCTURE. WE BELIEVE THAT A COMMUNITY HOSPITAL THAT IS SEEKING STRATEGIC TRANSITION INTO AN ACADEMIC CENTER BY ENGAGING MORE MEDICAL STUDENT EDUCATION OPPORTUNITIES, ESTABLISHING RESIDENCY AND FELLOWSHIP PROGRAMS, AND PROMOTING CLINICAL RESEARCH MAY REPRESENT SUCH CHALLENGES. THERE ARE SIGNIFICANT NEEDS TO INC

Posted 9/27/24